Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
BMC Neurology|October 9, 2021
Mindfulness training during brief periods of hospitalization in multiple sclerosis (MS): beneficial alterations in fatigue and the mediating role of depressionTorsten Sauder, Sascha Hansen, Carina Bauswein, et al.
BMC Neurology|March 10, 2022
The congruency of neuropsychological and F18-FDG brain PET/CT diagnostics of Alzheimer's Disease (AD) in routine clinical practice: insights from a mixed neurological patient cohortSascha Hansen, Jana Keune, Kim Küfner, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|August 4, 2017
Exploring resting-state EEG brain oscillatory activity in relation to cognitive functioning in multiple sclerosisPhilipp M Keune, Sascha Hansen, Emily Weber, et al.
Neuroimage|July 14, 2007
Distinct mechanisms of altered brain activation in patients with multiple sclerosisKatrin Morgen, Gebhard Sammer, Susan M Courtney, et al.
Neuroimage|December 20, 2005
Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MSKatrin Morgen, Gebhard Sammer, Susan M Courtney, et al.
BMC Neurology|September 25, 2015
Dynamic walking features and improved walking performance in multiple sclerosis patients treated with fampridine (4-aminopyridine)Philipp M Keune, Adam J Cocks, William R Young, et al.
Expert Review of Clinical Immunology|September 11, 2023
Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generationUwe Klaus Zettl, Paulus Stefan Rommer, Orhan Aktas, et al.
Journal of Neurology|April 15, 2004
Interferon-beta 1b leads to a short-term increase of soluble but long-term stabilisation of cell surface bound adhesion molecules in multiple sclerosisJoerg Kraus, Roland Bauer, Nikolaos Chatzimanolis, et al.
Therapeutic Advances in Neurological Disorders|January 7, 2020
Reasons to switch: a noninterventional study evaluating immunotherapy switches in a large German multicentre cohort of patients with relapsing-remitting multiple sclerosisMathias Mäurer, Klaus Tiel-Wilck, Eckard Oehm, et al.
Brain and Behavior|January 8, 2025
The Role of Atrial Fibrillation and Oral Anticoagulation Status in Health-Related Quality of Life 12 Months After Ischemic Stroke or TIAManuel C Olma, Lena Steindorf-Sabath, Serdar Tütüncü, et al.
Pageof 5